Lesley Goodburn
@lgoodbu
Followers
6K
Following
68K
Media
22K
Statuses
103K
Using @Sethsstory99 to improve end of life care & raise awareness of pancreatic cancer #sethslegacy Views are my own
Staffordshire
Joined May 2009
30 hats/outfits/shoes all in purple .2135 purple photos .6 presentations .2 conferences sharing @SethsStory99 .4 blogs .1 conference delivered.1 holding on dance with @FRONTLINEdance1 .100s of social media posts .1000s of conversations #sethslegacy.
3
4
24
Fresh hope for pancreatic cancer patients as new vaccine shows promise in early trial
news.sky.com
The new vaccine, which has shown promise in an early trial involving 20 pancreatic cancer patients and five with bowel cancer, has been developed to help the body's immune system find and attack...
0
0
0
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
487
235
3K
The kindness of strangers: sobbing in a rack of bras, a grandmotherly shop assistant soothed me
theguardian.com
Two months after my single mastectomy, I felt sore, sad and scarred. Looking for a suitable bra, I became completely overwhelmed
0
0
0
I’m happy to share that I’ve been involved as a Volunteer Director with @FrontlineDance. It's a great organization - please comment below or message me if you would like to learn more or get involved.
frontlinedance.co.uk
Lesley Goodburn has worked in healthcare for the last 18 years working locally in Stoke-on-Trent and Staffordshire, regionally in the West Midlands, and latterly nationally as the experience of care...
0
0
0
RT @SaraTurle: Wonderful to share another of my stories with cancer teams+other staff @EKHUFT 8am today. To share feelings+thoughts through….
0
3
0
OFD1 inhibition induces BRCAness to create a therapeutic vulnerability to PARP inhibition in pancreatic cancer | Nature Communications
nature.com
Nature Communications - PARP inhibitors are effective in cancer patients with BRCA1 mutations but whether this can extend to BRCA1 wildtype patients by targeting BRCA1 transcriptional regulation is...
0
0
0
Nanomaterial-Mediated Nucleic Acid Delivery for Pancreatic Cancer Therapeutics | ACS Applied Bio Materials
pubs.acs.org
Pancreatic cancer (PC), one of the most aggressive and lethal malignancies, remains an imminent threat to human health despite enormous advancements in cancer research. Traditional therapeutic...
0
0
0
Pat Smullen Cancer Trials Ireland Charity Race returns to the Curragh on Saturday August 30 – The Irish News
irishnews.com
Riders representing Cork, Dublin, Down, Galway, Kildare, Laois, Monaghan, Offaly, Tipperary, Waterford and Wicklow are taking part.
0
0
0
UNLV research team claims discovery could lead to finding cure for pancreatic cancer, diabetes
8newsnow.com
A research team at the University of Nevada, Las Vegas claims its latest discovery could eventually lead to curing pancreatic cancer and diabetes.
0
0
0
Amplia Therapeutics Releases New Topline Data from ACCENT Narmafotinib Pancreatic Cancer Trial.via @SmallCapsASX.
smallcaps.com.au
Amplia Therapeutics (ASX: ATX) has released new topline data from an ongoing trial of its best-in-class selective FAK inhibitor narmafotinib on advanced
0
0
0
Actuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh on Clinical Trial of Elraglusib in Combination with Retifanlimab and mFOLFIRINOX in Patients with Advanced Pancreatic Cancer
finance.yahoo.com
Clinical Trial Study to be Conducted at UPMC Hillman Cancer to Evaluate Novel Combination as Frontline Therapy CHICAGO and FORT WORTH, Texas, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics,...
0
0
0
Yoel Bakas: Pancreatic Cancer Machine Learning Research Shows Promise - OncoDaily
oncodaily.com
Yoel Bakas: Pancreatic Cancer Machine Learning Research Shows Promise / Allyson J. Ocean, Baptist Health Miami Cancer Institute, cancer, James Good, Matthew
0
0
0
mFOLFIRINOX and S-IROX vs Nab-Paclitaxel Plus Gemcitabine in Metastatic or Recurrent Pancreatic Cancer - The ASCO Post
ascopost.com
In an interim analysis of a Japanese phase II/III trial (GENERATE, JCOG1611) reported in the Journal of Clinical Oncology, Ohba et al compared the survival benefit of mFOLFIRINOX (modified fluorour...
0
0
0
Pfizer’s New Study on Ponsegromab: A Potential Breakthrough in Pancreatic Cancer Treatment
tipranks.com
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has announced a new clinical study titled ‘A Phase 2b/3, Randomized, Double-Bli...
0
0
0
Minimally Invasive Options Lead to Shorter Recovery Times in Pancreatic Cancer Surgery | Newswise
newswise.com
Pancreatic cancer begins in the pancreas, which is located behind the stomach. It is often difficult to detect early because symptoms typically appear only after the cancer has spread. As a result,...
0
0
0
Novel drug confirms NSD2 protein as therapeutic target in lung and pancreatic cancers | MD Anderson Cancer Center
mdanderson.org
Novel drug confirms NSD2 protein as therapeutic target in lung and pancreatic cancers
0
0
0
TTFields Combo Shows Meaningful Benefits in Pancreatic Adenocarcinoma via @@CancerNetwrk.
cancernetwork.com
Data from the PANOVA-3 trial may support the concomitant use of TTFields plus standard of care in solid tumors across different therapeutic settings.
0
0
0
Pancreatic Cancer Cases Increase in First 3 Years of Glycemic Evidence of Diabetes - Endocrinology Advisor
endocrinologyadvisor.com
New-onset type 2 diabetes, glycemically defined, is associated with a significantly increased risk for pancreatic cancer, especially among White individuals.
0
0
0
A special night to mark the 100th year of Yorkshire Cancer Research
greatbritishlife.co.uk
A Night Like No Other will be held on Saturday 27 September 2025 at Castle Howard
0
0
0
Researchers Find Link between Gene, Pancreatic Cancer Malignancy
japannews.yomiuri.co.jp
KYOTO (Jiji Press) — Researchers mainly from Kyoto University have found that impaired function of a specific gene contributes to the malignancy of pancreatic cancer, which is hard to treat with...
0
0
0